相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Antimicrobial susceptibility of Gram-negative bacteria from intensive care unit and non-intensive care unit patients from United States hospitals (2018-2020)
Helio S. Sader et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2022)
Clinically relevant mutations in core metabolic genes confer antibiotic resistance
Allison J. Lopatkin et al.
SCIENCE (2021)
Identification of Novel phoP-phoQ Regulated Genes that Contribute to Polymyxin B Tolerance in Pseudomonas aeruginosa
Baopeng Yang et al.
MICROORGANISMS (2021)
Gene-Gene Interactions Dictate Ciprofloxacin Resistance in Pseudomonas aeruginosa and Facilitate Prediction of Resistance Phenotype from Genome Sequence Data
Attika Rehman et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2021)
The Effects of Sub-inhibitory Antibiotic Concentrations on Pseudomonas aeruginosa: Reduced Susceptibility Due to Mutations
Kay A. Ramsay et al.
FRONTIERS IN MICROBIOLOGY (2021)
Predicting Pseudomonas aeruginosa susceptibility phenotypes from whole genome sequence resistome analysis
Sara Cortes-Lara et al.
CLINICAL MICROBIOLOGY AND INFECTION (2021)
β-lactam Resistance in Pseudomonas aeruginosa: Current Status, Future Prospects
Karl A. Glen et al.
PATHOGENS (2021)
Review of Ceftazidime-Avibactam for the Treatment of Infections Caused by Pseudomonas aeruginosa
George L. Daikos et al.
ANTIBIOTICS-BASEL (2021)
The environmental occurrence of Pseudomonas aeruginosa
Stephanie Crone et al.
APMIS (2020)
Predicting antimicrobial resistance in Pseudomonas aeruginosa with machine learning-enabled molecular diagnostics
Ariane Khaledi et al.
EMBO MOLECULAR MEDICINE (2020)
Adding Insult to Injury: Mechanistic Basis for How AmpC Mutations Allow Pseudomonas aeruginosa To Accelerate Cephalosporin Hydrolysis and Evade Avibactam
Cole L. Slater et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
Combination of MexAB-OprM overexpression and mutations in efflux regulators, PBPs and chaperone proteins is responsible for ceftazidime/avibactam resistance in Pseudomonas aeruginosa clinical isolates from US hospitals
Mariana Castanheira et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2019)
Bacterial metabolic state more accurately predicts antibiotic lethality than growth rate
Allison J. Lopatkin et al.
NATURE MICROBIOLOGY (2019)
Adapting to the Airways: Metabolic Requirements of Pseudomonas aeruginosa during the Infection of Cystic Fibrosis Patients
Ruggero La Rosa et al.
METABOLITES (2019)
Impact of Delayed Appropriate Antibiotic Therapy on Patient Outcomes by Antibiotic Resistance Status From Serious Gram-negative Bacterial Infections
Nicole Gidaya Bonine et al.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2019)
Regulation of AmpC-Driven β-Lactam Resistance in Pseudomonas aeruginosa: Different Pathways, Different Signaling
Gabriel Torrens et al.
MSYSTEMS (2019)
Genomics of antibiotic-resistance prediction in Pseudomonas aeruginosa
Julie Jeukens et al.
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES (2019)
Pathogen Distribution and Antimicrobial Resistance Among Pediatric Healthcare-Associated Infections Reported to the National Healthcare Safety Network, 2011-2014
Jason G. Lake et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2018)
Ceftazidime-Avibactam: A Review in the Treatment of Serious Gram-Negative Bacterial Infections
Matt Shirley
DRUGS (2018)
Mutation-Driven Evolution of Pseudomonas aeruginosa in the Presence of either Ceftazidime or Ceftazidime-Avibactam
Fernando Sanz-Garcia et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Pseudomonas aeruginosa adaptation and diversification in the non-cystic fibrosis bronchiectasis lung
Yasmin Hilliam et al.
EUROPEAN RESPIRATORY JOURNAL (2017)
Pseudomonas aeruginosa prevalence, antibiotic resistance and antimicrobial use in Chinese burn wards from 2007 to 2014
Yi Dou et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2017)
Muropeptide Binding and the X-ray Structure of the Effector Domain of the Transcriptional Regulator AmpR of Pseudomonas aeruginosa
David A. Dik et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2017)
Genomics and Susceptibility Profiles of Extensively Drug-Resistant Pseudomonas aeruginosa Isolates from Spain
Ester del Barrio-Tofino et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
The use of bloodstream infectiion mortality to measure the impactof antimicrobial stewardship interventions: assessing the evidence
Sonali Coulter et al.
INFECTIOUS DISEASE REPORTS (2017)
Evolution of Pseudomonas aeruginosa Antimicrobial Resistance and Fitness under Low and High Mutation Rates
Gabriel Cabot et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Overexpression of MexAB-OprM efflux pump in carbapenem-resistant Pseudomonas aeruginosa
Ya-ping Pan et al.
ARCHIVES OF MICROBIOLOGY (2016)
Pyomelanin-producing Pseudomonas aeruginosa selected during chronic infections have a large chromosomal deletion which confers resistance to pyocins
Didier Hocquet et al.
ENVIRONMENTAL MICROBIOLOGY (2016)
Role of Pseudomonas aeruginosa Low-Molecular-Mass Penicillin-Binding Proteins in AmpC Expression, β-Lactam Resistance, and Peptidoglycan Structure
Alaa Ropy et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Mutations in β-Lactamase AmpC Increase Resistance of Pseudomonas aeruginosa Isolates to Antipseudomonal Cephalosporins
M. Berrazeg et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
PROVEAN web server: a tool to predict the functional effect of amino acid substitutions and indels
Yongwook Choi et al.
BIOINFORMATICS (2015)
Precision-engineering the Pseudomonas aeruginosa genome with two-step allelic exchange
Laura R. Hmelo et al.
NATURE PROTOCOLS (2015)
Loss of membrane-bound lytic transglycosylases increases outer membrane permeability and β-lactam sensitivity in Pseudomonas aeruginosa
Ryan P. Lamers et al.
MICROBIOLOGYOPEN (2015)
Mutation-Driven β-Lactam Resistance Mechanisms among Contemporary Ceftazidime-Nonsusceptible Pseudomonas aeruginosa Isolates from US Hospitals
Mariana Castanheira et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Changes to Its Peptidoglycan-Remodeling Enzyme Repertoire Modulate β-Lactam Resistance in Pseudomonas aeruginosa
Joseph F. Cavallari et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Clinical relevance of the ESKAPE pathogens
Jack N. Pendleton et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2013)
Pan-β-Lactam Resistance Development in Pseudomonas aeruginosa Clinical Strains: Molecular Mechanisms, Penicillin-Binding Protein Profiles, and Binding Affinities
Bartolome Moya et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Sequence-Verified Two-Allele Transposon Mutant Library for Pseudomonas aeruginosa PAO1
Kiara Held et al.
JOURNAL OF BACTERIOLOGY (2012)
Genetic Determinants Involved in the Susceptibility of Pseudomonas aeruginosa to β-Lactam Antibiotics
Carolina Alvarez-Ortega et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Differential β-lactam resistance response driven by ampD or dacB (PBP4) inactivation in genetically diverse Pseudomonas aeruginosa strains
Laura Zamorano et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
Genomewide Identification of Genetic Determinants of Antimicrobial Drug Resistance in Pseudomonas aeruginosa
Andreas Doetsch et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
An improved Escherichia coli donor strain for diparental mating
Sabrina Thoma et al.
FEMS MICROBIOLOGY LETTERS (2009)
β-Lactam Resistance Response Triggered by Inactivation of a Nonessential Penicillin-Binding Protein
Bartolome Moya et al.
PLOS PATHOGENS (2009)
Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances
Irith Wiegand et al.
NATURE PROTOCOLS (2008)
分享论文
